These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


80 related items for PubMed ID: 8446228

  • 1. Acute right ventricular heart failure in a patient with renal cell carcinoma after interferon therapy.
    Kramers C, de Mulder PH, Barth JD, Wagener DJ.
    Neth J Med; 1993 Feb; 42(1-2):65-8. PubMed ID: 8446228
    [Abstract] [Full Text] [Related]

  • 2. [Gamma-interferon-induced cardiomyopathy during treatment of renal cell carcinoma: a case report].
    Morino Y, Hara K, Ushikoshi H, Tanabe K, Kuroda Y, Noguchi T, Ayabe S, Hara H, Yanbe Y, Kozuma K, Ikari Y, Saeki F, Tamura T.
    J Cardiol; 2000 Jul; 36(1):49-57. PubMed ID: 10929266
    [Abstract] [Full Text] [Related]

  • 3. [Dilated cardiomyopathy following alpha interferon therapy of renal tumor with pulmonary metastases: a case report].
    Kura N, Kojima S, Kakehi R, Yokoyama H, Fujiwara T, Gotoh S.
    Hinyokika Kiyo; 1992 Sep; 38(9):1051-4. PubMed ID: 1414758
    [Abstract] [Full Text] [Related]

  • 4. [Clinical trial of inhalant recombinant interferon-gamma in patients with pulmonary metastasis from renal tumor (preliminary report)].
    Kawata N, Takimoto Y, Hirakata H, Fuse T, Hirano D, Yamanaka Y.
    Hinyokika Kiyo; 1994 Sep; 40(9):773-6. PubMed ID: 7801837
    [Abstract] [Full Text] [Related]

  • 5. [A case of pulmonary metastasis from renal cell carcinoma in which complete remission was achieved by interferon therapy (r-IFN-alpha A, Ro 22-8181)].
    Ishito N, Wada F, Aramaki K, Asano S, Johsen T.
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):380-3. PubMed ID: 3947113
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
    Hillman GG, Younes E, Visscher D, Hamzavi F, Kim S, Lam JS, Montecillo EJ, Ali E, Pontes JE, Puri RK, Haas GP.
    Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. New prospects in the management of metastatic renal cell carcinoma. Experimental and clinical data.
    Debruyne FM, Franssen MP, Beniers AJ, Schalken JA, de Mulder PH.
    Prog Clin Biol Res; 1990 Oct; 350():243-55. PubMed ID: 2117284
    [No Abstract] [Full Text] [Related]

  • 10. [A case study of metastatic renal cell carcinoma in lungs showing complete response to continuous subcutaneous injection of interferon alpha and gamma].
    Kawata N, Hirakata H, Igarashi T, Minei S, Hamano K, Kodama M, Yamamoto T, Takimoto Y.
    Hinyokika Kiyo; 1996 Jul; 42(7):509-12. PubMed ID: 8809559
    [Abstract] [Full Text] [Related]

  • 11. [Prolonged complete remission of multiple organ metastases after radical nephrectomy induced by interferon-alpha therapy: a case report].
    Hirano A, Fujita T, Kimura T, Katoh M, Tsuji Y, Kinukawa T, Nojiri Y.
    Hinyokika Kiyo; 2006 Dec; 52(12):941-5. PubMed ID: 17252978
    [Abstract] [Full Text] [Related]

  • 12. Correlation of clinical and immunological parameters of metastatic renal cell carcinoma patients undergoing therapy with interleukin 2, interferon-alpha and retinoic acid.
    Elsässer-Beile U, Kölble N, Grussenmeyer T, Wetterauer U, Schultze-Seemann W.
    Anticancer Res; 1998 Dec; 18(3B):1883-90. PubMed ID: 9677439
    [Abstract] [Full Text] [Related]

  • 13. [Three cases of lung metastases of renal cell carcinoma treated with a combination of interferon-alpha, 5-fluorouracil and leucovorin].
    Togashi M, Tabata T, Hirakawa K, Ohashi N, Sindoh J, Hirano T, Demura T.
    Hinyokika Kiyo; 1996 Jan; 42(1):43-5. PubMed ID: 8686582
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Successful treatment for renal cell carcinoma with lung metastases by interleukin-2 and interferon-alfa: a case report].
    Sakata Y, Ogura Y, Wakita T, Hayashi N, Sugimura Y.
    Hinyokika Kiyo; 2003 Jul; 49(7):389-91. PubMed ID: 12968479
    [Abstract] [Full Text] [Related]

  • 16. [Interleukin 2 based ambulatory therapy of metastatic renal cell carcinoma].
    Atzpodien J, Kirchner H, Poliwoda H.
    Med Klin (Munich); 1996 Apr 12; 91 Suppl 3():38-43. PubMed ID: 8692118
    [Abstract] [Full Text] [Related]

  • 17. Multi-modal treatment of primarily using continuous subcutaneous interferon-alpha injection in combination with surgery and/or radiotherapy.
    Maruoka M, Fujimura M, Kawamura K, Suzuki S, Hamano M, Nishikawa Y, Nagayama T.
    Int J Urol; 2005 May 12; 12(5):442-8. PubMed ID: 15948742
    [Abstract] [Full Text] [Related]

  • 18. Cyclic interferon gamma application in patients with renal cell carcinoma.
    Grups JW, Frohmüller HG.
    Prog Clin Biol Res; 1990 May 12; 350():257-62. PubMed ID: 2117285
    [No Abstract] [Full Text] [Related]

  • 19. Combination therapy with subcutaneous interleukin-2 and interferon-alpha in advanced renal cancer patients with poor prognostic factors.
    Canobbio L, Curotto A, Cannata D, Miglietta L, Lavarello A, Giglio C, Franchini R, Cussotto M, Boccardo F.
    Anticancer Res; 1996 May 12; 16(1):541-4. PubMed ID: 8615668
    [Abstract] [Full Text] [Related]

  • 20. Multifocal metastases of recurrent renal cell carcinoma successfully treated with a combination of low dose interleukin-2, alpha-interferon and radiotherapy.
    Sawada N, Fukasawa M, Araki I, Kira S, Manabu K, Takeda M.
    Int J Urol; 2005 Nov 12; 12(11):994-5. PubMed ID: 16351657
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.